{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:40Z","timestamp":1759048180588},"reference-count":25,"publisher":"Japanese Society of Toxicologic Pathology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Toxicol Pathol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1293\/tox.2019-0030","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T18:03:40Z","timestamp":1568397820000},"page":"305-310","source":"Crossref","is-referenced-by-count":3,"title":["Increased circulating peroxiredoxin-4 in sepsis model rats involves secretion          from hepatocytes and is mitigated by GYY4137"],"prefix":"10.1293","volume":"32","author":[{"given":"Kana","family":"Unuma","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine, Graduate School of              Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima,              Bunkyo-ku, Tokyo 113-8519, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Graduate School of              Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima,              Bunkyo-ku, Tokyo 113-8519, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Aki","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Graduate School of              Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima,              Bunkyo-ku, Tokyo 113-8519, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Graduate School of              Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima,              Bunkyo-ku, Tokyo 113-8519, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"121","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.  Schulte              J.            Peroxiredoxin 4: a multifunctional biomarker worthy of further            exploration. BMC Med. 9:            137. 2011.","DOI":"10.1186\/1741-7015-9-137"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2.  Yamada              S, and                Guo              X.            Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of            metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver            disease. Pathol Int. 68:            91\u2013101. 2018.","DOI":"10.1111\/pin.12634"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.  Okado-Matsumoto              A,                Matsumoto              A,                Fujii              J, and                Taniguchi              N.            Peroxiredoxin IV is a secretable protein with heparin-binding properties            under reduced conditions. J Biochem.            127: 493\u2013501. 2000.","DOI":"10.1093\/oxfordjournals.jbchem.a022632"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4.  Matsumoto              A,                Okado              A,                Fujii              T,                Fujii              J,                Egashira              M,                Niikawa              N, and                Taniguchi              N. Cloning of            the peroxiredoxin gene family in rats and characterization of the fourth            member. FEBS Lett. 443:            246\u2013250. 1999.","DOI":"10.1016\/S0014-5793(98)01736-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5.  Tavender              TJ, and                Bulleid              NJ.            Peroxiredoxin IV protects cells from oxidative stress by removing H2O2            produced during disulphide formation. J Cell Sci.            123: 2672\u20132679. 2010.","DOI":"10.1242\/jcs.067843"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.  Abbasi              A,                Corpeleijn              E,                Postmus              D,                Gansevoort              RT,                de Jong              PE,                Gans              RO,                Struck              J,                Schulte              J,                Hillege              HL,                van der Harst              P,                Peelen              LM,                Beulens              JW,                Stolk              RP,                Navis              G, and                Bakker              SJ.            Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and            the risk of incident cardiovascular disease and all-cause mortality.            J Am Heart Assoc. 1: e002956.            2012.","DOI":"10.1161\/JAHA.112.002956"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.  Gerrits              EG,                Alkhalaf              A,                Landman              GW,                van Hateren              KJ,                Groenier              KH,                Struck              J,                Schulte              J,                Gans              RO,                Bakker              SJ,                Kleefstra              N, and                Bilo              HJ. Serum            peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2            diabetes (ZODIAC-28). PLoS One. 9:            e89719. 2014.","DOI":"10.1371\/journal.pone.0089719"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8.  Schulte              J,                Struck              J,                K\u00f6hrle              J, and                M\u00fcller              B. Circulating            levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with            sepsis. Shock. 35:            460\u2013465. 2011.","DOI":"10.1097\/SHK.0b013e3182115f40"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.  Strnad              P,                Tacke              F,                Koch              A, and                Trautwein              C. Liver -            guardian, modifier and target of sepsis. Nat Rev Gastroenterol            Hepatol. 14: 55\u201366.            2017.","DOI":"10.1038\/nrgastro.2016.168"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.  Sarady              JK,                Zuckerbraun              BS,                Bilban              M,                Wagner              O,                Usheva              A,                Liu              F,                Ifedigbo              E,                Zamora              R,                Choi              AM, and                Otterbein              LE. Carbon            monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the            lung and liver. FASEB J. 18:            854\u2013856. 2004.","DOI":"10.1096\/fj.03-0643fje"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.  Ryter              SW, and                Choi              AM.            Cytoprotective and anti-inflammatory actions of carbon monoxide in organ            injury and sepsis models. Novartis Found Symp.            280: 165\u2013175, discussion 175\u2013181.            2007.","DOI":"10.1002\/9780470059593.ch12"},{"key":"12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/SHK.0b013e3182736688","volume":"39","year":"2013","unstructured":"12.  Norris              EJ,                Larion              S,                Culberson              CR, and                Clemens              MG. Hydrogen            sulfide differentially affects the hepatic vasculature in response to phenylephrine and            endothelin 1 during endotoxemia. Shock.            39: 168\u2013175. 2013.","journal-title":"Shock","ISSN":"http:\/\/id.crossref.org\/issn\/1073-2322","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.  Unuma              K,                Aki              T,                Nagano              S,                Watanabe              R, and                Uemura              K. The            down-regulation of cardiac contractile proteins underlies myocardial depression during            sepsis and is mitigated by carbon monoxide. Biochem Biophys Res            Commun. 495: 1668\u20131674.            2018.","DOI":"10.1016\/j.bbrc.2017.12.020"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14.  Unuma              K,                Aki              T,                Noritake              K,                Funakoshi              T, and                Uemura              K. A            CO-releasing molecule prevents annexin A2 down-regulation and associated disorders in            LPS-administered rat lung. Biochem Biophys Res Commun.            487: 748\u2013754. 2017.","DOI":"10.1016\/j.bbrc.2017.04.131"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15.  Li              L,                Whiteman              M,                Guan              YY,                Neo              KL,                Cheng              Y,                Lee              SW,                Zhao              Y,                Baskar              R,                Tan              CH, and                Moore              PK.            Characterization of a novel, water-soluble hydrogen sulfide-releasing            molecule (GYY4137): new insights into the biology of hydrogen sulfide.            Circulation. 117:            2351\u20132360. 2008.","DOI":"10.1161\/CIRCULATIONAHA.107.753467"},{"key":"16","unstructured":"16.  Nemzek              JA,                Hugunin              KM, and                Opp              MR. Modeling            sepsis in the laboratory: merging sound science with animal well-being.            Comp Med. 58: 120\u2013128.            2008."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17.  Fink              MP. Animal            models of sepsis. Virulence. 5:            143\u2013153. 2014.","DOI":"10.4161\/viru.26083"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18.  Aki              T,                Unuma              K,                Noritake              K,                Kurahashi              H,                Funakoshi              T, and                Uemura              K. Interaction            of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma            fibronectin. Toxicol In Vitro. 50:            201\u2013209. 2018.","DOI":"10.1016\/j.tiv.2018.03.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.  Unuma              K,                Aki              T,                Funakoshi              T,                Hashimoto              K, and                Uemura              K. Extrusion of            mitochondrial contents from lipopolysaccharide-stimulated cells: Involvement of            autophagy. Autophagy. 11:            1520\u20131536. 2015.","DOI":"10.1080\/15548627.2015.1063765"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20.  Unuma              K,                Aki              T,                Matsuda              S,                Funakoshi              T,                Yoshida              K, and                Uemura              K. Elimination            and active extrusion of liver mitochondrial proteins during lipopolysaccharide            administration in rat. Hepatol Res.          43: 526\u2013534. 2013.","DOI":"10.1111\/j.1872-034X.2012.01084.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.  Unuma              K,                Aki              T,                Matsuda              S,                Funakoshi              T,                Yoshida              K, and                Uemura              K. Inducer of            heme oxygenase-1 cobalt protoporphyrin accelerates autophagy and suppresses oxidative            damages during lipopolysaccharide treatment in rat liver.            Hepatol Res. 43: 91\u201396.            2013.","DOI":"10.1111\/j.1872-034X.2012.01049.x"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22.  Dinarello              CA.            Proinflammatory and anti-inflammatory cytokines as mediators in the            pathogenesis of septic shock. Chest.            112(Suppl):            321S\u2013329S. 1997.","DOI":"10.1378\/chest.112.6_Supplement.321S"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23.  Shichita              T,                Hasegawa              E,                Kimura              A,                Morita              R,                Sakaguchi              R,                Takada              I,                Sekiya              T,                Ooboshi              H,                Kitazono              T,                Yanagawa              T,                Ishii              T,                Takahashi              H,                Mori              S,                Nishibori              M,                Kuroda              K,                Akira              S,                Miyake              K, and                Yoshimura              A.            Peroxiredoxin family proteins are key initiators of post-ischemic            inflammation in the brain. Nat Med.          18: 911\u2013917. 2012.","DOI":"10.1038\/nm.2749"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24.  Zhao              LX,                Du              JR,                Zhou              HJ,                Liu              DL,                Gu              MX, and                Long              FY. Differences            in proinflammatory property of six subtypes of peroxiredoxins and anti-inflammatory            effect of ligustilide in macrophages. PLoS One.            11: e0164586. 2016.","DOI":"10.1371\/journal.pone.0164586"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.  Brenner              C,                Galluzzi              L,                Kepp              O, and                Kroemer              G. Decoding            cell death signals in liver inflammation. J Hepatol.            59: 583\u2013594. 2013.","DOI":"10.1016\/j.jhep.2013.03.033"}],"container-title":["Journal of Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/32\/4\/32_2019-0030\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T23:46:33Z","timestamp":1572047193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tox\/32\/4\/32_2019-0030\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1293\/tox.2019-0030","relation":{},"ISSN":["0914-9198","1881-915X"],"issn-type":[{"value":"0914-9198","type":"print"},{"value":"1881-915X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}